loader2
Partner With Us NRI

Vaishali Pharma Ltd share Price Today

Company details

155.99
159.74
114.85
203.60
6M Return -12.46%
1Y Return 27.65%
Mkt Cap.(Cr) 181.10
Volume 127,336
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 127,336

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Vaishali Pharma Ltd shares SWOT Analysis

Strengths (5)

  • Company with Low Debt
  • Increasing Revenue every quarter for the past 2 quarters
  • Book Value per share Improving for last 2 years

Weakness (4)

  • Negative profit growth, promoters decreasing shareholding QoQ
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Opportunity (0)

Data not found

Threats (3)

  • Promoter decreasing their shareholding
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 159.1
R2 161.3
R3 162.8
Pivot

157.54

S1 155.3
S2 153.8
S3 151.6
EMA SMA
156.6
155.3
155.2
152.1
157.7
154.5
153.5
154.9
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GANDHI BHAVER AMRITLAL Bulk Purchase 2024-07-04 167.33 99232 NSE
GANDHI BHAVER AMRITLAL Bulk Sell 2024-07-04 163.29 51232 NSE
ALTAB USMANBHAI PATHAN Bulk Purchase 2024-06-24 161.75 84679 NSE
Name Category Shares
ATUL ARVINDBHAI VASANI PROMOTER 19.59%
JAGRUTI ATUL VASANI PROMOTER 4.16%
BHARTI KIRITKUMAR TOLIA PROMOTER 0.62%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Vaishali Pharma Ltd Stocks COMPARISON

Financials( in Cr) Vaishali Pharma Ltd Adani Enterprises Ltd Aegis Logistics Ltd Cello World Ltd Redington Ltd
Price 156.88 3,109.30 897.45 990.30 207.94
% Change 0.34 0.43 -1.30 3.32 -0.64
Mcap Cr 181.10 354,460.51 31,500.50 21,017.24 16,256.21
Revenue TTM Cr 69.66 96,420.98 7,045.92 1,796.70 89,345.71
Net Profit TTM Cr 6.60 3,294.63 672.20 285.07 1,238.61
PE TTM 234.15 100.78 56.17 66.05 13.39
1 Year Return 27.65 29.00 148.70 25.09 10.28
ROCE 21.59 8.94 16.09 45.20 19.80
ROE 19.73 9.14 18.10 134.44 17.11
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 40.54 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,424.68 50,451.86
LAST 3M 101,404.97 51,097.20
LAST 6M 186,293.66 40,305.54
LAST 12M 309,547.75 87,515.42

Vaishali Pharma Ltd Information

Stock PE (TTM)
234.15
Promoter Holding
25.77%
Book Value
39.9649
ROCE
21.59%
ROE
19.73%
Description
  • Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name "Vaishali Pharma Private Limited" on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company. Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 formulation brands marketed in multiple countries; of which dossier is in CTD format along with its respective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Company`s synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients. In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments & Medical Devices Directive. In addition, the Company has also been recognized by Government of India as `One Star Export House` and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.

Registered Address

706 to 709 7th Floor Aravali, Business Centre Borivali(W), Mumbai, Maharashtra, 400092

Tel : 91-22-28928833
Email : investor:vaishalipharma.com
Website : http://www.vaishalipharma.com
Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 535000
NSE Code : VAISHALI
Book Closure Date (Month) : Sep
BSE Group :
ISIN : INE972X01014

FAQ’s on Vaishali Pharma Ltd Shares

You can buy Vaishali Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vaishali Pharma Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 16, 2024 03:59 PM the closing price of Vaishali Pharma Ltd was Rs.156.88.

The latest PE ratio of Vaishali Pharma Ltd as of Jul 16, 2024 03:59 PM is 234.15

The latest PB ratio of Vaishali Pharma Ltd as of Jul 16, 2024 03:59 PM is 0.25

The 52-week high of Vaishali Pharma Ltd share price is Rs. 203.60 while the 52-week low is Rs. 114.85

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 16, 2024 03:59 PM, the market cap of Vaishali Pharma Ltd stood at Rs. 181.10 Cr.

Download App

Download Our App

Play Store App Store
market app